Oncocur
Next Generation Nanoparticles based Precision Therapeutics
Oncocur
Next Generation Nanoparticles based Precision Therapeutics
About us
ONCOCUR is an emerging nanomedicine company with a focus on next generation nanoparticles based precision therapeutics for oncology. Nanoparticle drugs has the potential to work against multi drug resistance deadly cancers, and offers better therapeutic index by selective targeting, lower drug toxicity, greater intracellular availability and gene regulation.
Read more
Nonomedicine
Oral Delivery
Chemo-Immune Therapy
Breast Cancer
What clients say about us:
Effective relapse preventive anti-cancer drug. Fastens healing post surgery. Complementary to primary anti-cancer drugs. Effective in bone metastasis prevention. Reduces hepatocellular toxicity and improves quality of life. Acts as an immunomodulator and calcium supplement.
Rahul KhandXXXXX
